American and Korean scientists have created a human disease model-on-a-chip that mimics pulmonary edema using a biomimetic microdevice that reconstitutes organ-level lung functions.
Scientists from the Department of Pharmacy at the Saarland University and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) have developed a drug-delivery system that looks like a corn cob.
A team of scientists have been successfully in cultivating stem cells from human heart muscle tissue that can contract just as strong as natural tissue.
Prof. Hans Schöler´s team from the Max Planck Institute (MPI) for Molecular Biomedicine in Münster have developed a stem cell-based technique for the neurodegenerative disease amyotrophic lateral sclerosis (ALS).
A German research team has analyzed 4,000 blood samples, which derived from different research projects. In so-called metabolome analysis they identified 14 novel biomarkers for type 2 diabetes.
Researchers from Helmholtz Zentrum München have converted glial cells (supporting cells) directly into functional nerve cells, which play normally an important role in wound healing and information processing of neurons.
The chemical company BASF SE has provided U.S. based Institute for In Vitro Sciences (IIVS) with equipment critical to replacing the use of animals for eye irritation testing of certain chemicals. IIVS will place the units at each of its newly developed training laboratories in Xi'an, Beijing, and Guangzhou, China.
The US Food and Drug Administration (FDA) wants to collaborate with European researchers in developing new toxicology tools that advance non-animal based safety science and health research.
Scientists from Helmholtz Centre for Infection Research (HZI) and the Saarland University have unraveled the physical properties of the lung mucus. They found out that in lung mucus a stiff gel scaffold seperates large fluid-filled pores from each other and prevents the movement of nanoparticles via pore boundaries.
At the 18th of October the European Coalition to End Animal Experiments (ECEAE) presented about 240,000 signatures from the No Cruel Cosmetics campaign to the Petitions Committee of the European Parliament. The aim is to end the import and sale of cosmetics tested on animals in Europe. InVitroJobs was also resented.